Literature DB >> 1547920

Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy.

S Tesfaye1, N D Harris, R M Wilson, J D Ward.   

Abstract

Severe microvascular disease exists at the stage of clinical diabetic neuropathy. A non-invasive test that will identify those diabetic subjects who will eventually develop neuropathy is essential for early intervention. Sural sensory conduction velocity was recorded (x3) in 12 non-neuropathic diabetic subjects, 15 diabetic subjects with established neuropathy and 16 age-matched normal control subjects, before and after exercise to 80% age/sex predicted maximum heart rate. Fixed sural electrodes were used. Subcutaneous temperature was recorded by a needle thermocouple placed near the sural nerve. Sural sensory conduction velocity increased significantly after exercise in normal subjects (p less than 0.01, mean increase 5.07 m/s) and non-neuropathic diabetic subjects (p less than 0.02, mean increase 3.99 m/s) but not in neuropathic subjects (mean increase 0.99 m/s). Subcutaneous temperature rose significantly in normal subjects (p less than 0.01, mean increase 2.07 degrees C) and non-neuropathic diabetic subjects (p less than 0.001, mean increase 2.52 degrees C) but not in neuropathic subjects (mean increase 0.15 degree C). However, sural sensory conduction velocity increased by 1.2 m.s-1.degree C-1 following direct warming of the limb in six neuropathic subjects which was comparable to that of normal and non-neuropathic subjects (1.49 and 1.48 m.s-1. degree C-1). The impairment of exercise conduction increment in diabetic neuropathy suggests impaired nerve blood flow in diabetic neuropathy.

Entities:  

Mesh:

Year:  1992        PMID: 1547920     DOI: 10.1007/bf00402548

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy.

Authors:  H Yasuda; P J Dyck
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

3.  Electrophysiologic responses of human sural nerve to temperature.

Authors:  D G Greathouse; D P Currier; B S Joseph; R L Shippee; D H Matulionis
Journal:  Phys Ther       Date:  1989-11

4.  Electrocardiographic changes in clinically normal older men following near maximal and maximal exercise.

Authors:  F M Lester; L T Sheffield; T J Reeves
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

5.  Small vessel disease in progressive diabetic neuropathy associated with good metabolic control.

Authors:  W R Timperley; A J Boulton; G A Davies-Jones; J A Jarratt; J D Ward
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

6.  Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.

Authors:  P J Dyck; B R Zimmerman; T H Vilen; S R Minnerath; J L Karnes; J K Yao; J F Poduslo
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Intima of epineurial arterioles is increased in diabetic polyneuropathy.

Authors:  J K Korthals; M A Gieron; P J Dyck
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

Review 8.  Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture.

Authors:  P J Dyck
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

9.  Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy.

Authors:  P J Dyck; A Lais; J L Karnes; P O'Brien; R Rizza
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

10.  Pathogenesis of diabetic neuropathy.

Authors:  P C Johnson; S C Doll; D W Cromey
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

View more
  20 in total

1.  Reversal of experimental diabetic neuropathy by VEGF gene transfer.

Authors:  P Schratzberger; D H Walter; K Rittig; F H Bahlmann; R Pola; C Curry; M Silver; J G Krainin; D H Weinberg; A H Ropper; J M Isner
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis).

Authors:  S Tesfaye; R Malik; N Harris; J J Jakubowski; C Mody; I G Rennie; J D Ward
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

3.  Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation.

Authors:  L Reichstein; S Labrenz; D Ziegler; S Martin
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

4.  Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.

Authors:  E Bosi; M Conti; C Vermigli; G Cazzetta; E Peretti; M C Cordoni; G Galimberti; L Scionti
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

Review 5.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

6.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography.

Authors:  S Tesfaye; N Harris; J J Jakubowski; C Mody; R M Wilson; I G Rennie; J D Ward
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

7.  Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.

Authors:  E K Maxfield; N E Cameron; M A Cotter; K C Dines
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.

Authors:  N E Cameron; M A Cotter; K C Dines; S Robertson; D Cox
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

10.  Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy?

Authors:  M J Young; A Veves; M G Walker; A J Boulton
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.